
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
New Trading Tool: Live US Options Flow! Try it out.
Our engineers are aware of and working on the problem with on-site streaming.
Register for Free to get streaming quotes, interactive charts, trades, portfolio, live options flow and more.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Arecor Therapeutics Plc | LSE:AREC | London | Ordinary Share | GB00BMWLM973 | ORD GBP0.01 |
Price Change | % Change | Share Price | Bid Price | Offer Price | |
---|---|---|---|---|---|
0.00 | 0.0% |
High Price | Low Price | Open Price | Shares Traded | Last Trade |
---|---|---|---|---|
0.00 | - |
Industry Sector | Turnover (m) | Profit (m) | EPS - Basic | PE Ratio | Market Cap (m) |
---|---|---|---|---|---|
Coml Physical, Biologcl Resh | 3.5 | -9.3 | -30.2 | - | 0.00 |
Date | Time | Source | Headline |
---|---|---|---|
15/9/2023 | 07:00 | RNSNON | Arecor Therapeutics PLC Arecor on Investor Meet Company Platform |
14/9/2023 | 12:05 | ALNC | ![]() |
14/9/2023 | 07:00 | UKREG | Arecor Therapeutics PLC Interim Results for six months ended 30 June 2023 |
07/9/2023 | 17:07 | ALNC | ![]() |
07/9/2023 | 10:35 | DJN | Arecor Therapeutics Partner Hikma Advances on Review of AT307 in US |
07/9/2023 | 07:00 | UKREG | Arecor Therapeutics PLC Arecor: positive Hikma FDA pre-IND meeting |
04/9/2023 | 12:25 | ALNC | ![]() |
04/9/2023 | 07:00 | RNSNON | Arecor Therapeutics PLC TETRIS PHARMA ANNOUNCES AGREEMENT WITH GOODLIFE |
17/8/2023 | 09:51 | ALNC | ![]() |
17/8/2023 | 07:00 | UKREG | Arecor Therapeutics PLC Collaboration With Top 10 Global Pharma |
1 Year Arecor Therapeutics Chart |
Intraday Arecor Therapeutics Chart |
Your Recent History | |||||||
Register now to watch these stocks streaming on the ADVFN Monitor.
Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use. Log in to ADVFN
Register Now |
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions Support: +44 (0) 203 8794 460 | support@advfn.com |
ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil |
ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico |
ADVFN France ADVFN US ADVFN Korea |
V: D: 20230924 15:31:25 |